Early research (Phase 1)Study completedNCT00006279
What this trial is testing
The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75